34.00
+0.3(+0.89%)
Currency In USD
| Previous Close | 33.7 |
| Open | 33.58 |
| Day High | 34.71 |
| Day Low | 33.58 |
| 52-Week High | 66.54 |
| 52-Week Low | 26.29 |
| Volume | 316,252 |
| Average Volume | 762,085 |
| Market Cap | 1.37B |
| PE | -41.98 |
| EPS | -0.81 |
| Moving Average 50 Days | 37.05 |
| Moving Average 200 Days | 49.06 |
| Change | 0.3 |
If you invested $1000 in RxSight, Inc. (RXST) since IPO date, it would be worth $2,125 as of February 05, 2025 at a share price of $34. Whereas If you bought $1000 worth of RxSight, Inc. (RXST) shares 3 years ago, it would be worth $2,992.96 as of February 05, 2025 at a share price of $34.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
GlobeNewswire Inc.
Jan 12, 2025 2:30 PM GMT
ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain prelim
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 02, 2025 9:05 PM GMT
ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to parti
RxSight, Inc. Reports Third Quarter 2024 Financial Results
GlobeNewswire Inc.
Nov 07, 2024 9:05 PM GMT
ALISO VIEJO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial resu